0001694665-23-000046.txt : 20230510 0001694665-23-000046.hdr.sgml : 20230510 20230510171153 ACCESSION NUMBER: 0001694665-23-000046 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230507 FILED AS OF DATE: 20230510 DATE AS OF CHANGE: 20230510 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GILL SIMBA CENTRAL INDEX KEY: 0001180763 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-38473 FILM NUMBER: 23907624 MAIL ADDRESS: STREET 1: 515 GALVESTON DR CITY: REDWOOD CITY STATE: CA ZIP: 94063 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Evelo Biosciences, Inc. CENTRAL INDEX KEY: 0001694665 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 465594527 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 620 MEMORIAL DRIVE SUITE 500 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-577-0300 MAIL ADDRESS: STREET 1: 620 MEMORIAL DRIVE SUITE 500 CITY: CAMBRIDGE STATE: MA ZIP: 02139 4/A 1 wf-form4a_168375309729647.xml FORM 4/A X0407 4/A 2023-05-07 2023-05-09 0 0001694665 Evelo Biosciences, Inc. EVLO 0001180763 GILL SIMBA C/O EVELO BIOSCIENCES, INC. 620 MEMORIAL DRIVE CAMBRIDGE MA 02139 1 1 0 0 President & CEO 0 Restricted Stock Units 2023-05-07 4 M 0 23437 0 D Common Stock 23437.0 351563 D Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock. The RSUs vest in sixteen (16) substantially equal quarterly installments following the February 07, 2023 grant date, such that all of the Restricted Stock Units will become vested on the fourth anniversary of the grant date, subject to the reporting person's continued service to the issuer on each such vesting date. The RSUs have no expiration date. This Form 4/A is being filed to disclose the disposition of 23,437 RSUs. Column 5 of Table II in the Form 4 filed on May 9, 2023 inadvertently and improperly showed that these securities were acquired. Column 9 of Table II remains unchanged from the May 9, 2023 filing. /s/ Marella Thorell, Attorney-in-Fact for Balkrishan (Simba) Gill, Ph.D. 2023-05-10